A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)

Not Applicable

Terminated

Conditions: Neurologic Deficits
Spondylolisthesis
Kyphosis
Pseudarthrosis

Interventions: Device: Dynamic Stabilization System (DSS)

Registration Number: NCT01461005

Lead Sponsor: Paradigm Spine

Brief Summary: The purpose of the Post-Market Surveillance study is to evaluate safety.

Detailed Description: Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center, literature controlled study.

Recruitment & Eligibility

Status: TERMINATED

Sex: All

Target Recruitment: 1

Inclusion Criteria

Patient is skeletally mature (21-85 years old).
Patient has degenerative spondylolisthesis (Grade 1-3) with objective evidence of neurologic impairment, kyphosis, and/or failed previous fusion (pseudarthrosis) at index level.
Capable and willing to comply with the requirements unique to the study, adhere to the post-operative treatment and management program, and return for required follow-up examinations.
Surgeon has determined that DSS™ System is an appropriate treatment for the patient without regard to the study.

Exclusion Criteria

The need for interbody cages, allograft, or any other assistance during surgery. Device is only to be used with autograft per FDA approved indications.
Any medical, mental or surgical condition precluding the potential benefit of spinal surgery or surgery in general.
Acute or chronic systemic, spinal or localized infections.
Active, severe systemic and metabolic diseases.
Obesity defined as Body Mass Index > 35.
Subject is pregnant or interested in becoming pregnant in the next 36 months.
Dependency on pharmaceutical drugs, drug abuse, or alcoholism.
Lack of patient cooperation.
Foreign body sensitivity to the implant material.
Degenerative scoliosis greater than 25 degrees.
Grade 4 degenerative spondylolisthesis (>75% slip).
Significant osteopenia A screening questionnaire for osteopenia, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients who require a DEXA bone mineral density measurement. If DEXA is required*, exclusion will be defined as a DEXA bone density measured T score of ≤ -1.0 (The World Health Organization definition of osteopenia).
Soft tissue deficit not allowing wound closure.
Congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of the device.
Inadequate pedicles or vertebral body geometry of the thoracic, lumbar and sacral vertebrae.
Bony lumbar spinal stenosis not related to the primary degenerative spondylolisthesis indication.
Pars defect.
Clinically compromised vertebral bodies at affected level due to current or past trauma.
Prisoner or ward of the state.
Currently in litigation regarding a spinal condition.
Known allergy to titanium, titanium alloys, CoCrMo, polyethylene or MR contrast agents.
Is currently involved in a study of another investigational product for similar purpose.

Study & Design

Study Type: INTERVENTIONAL

Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Dynamic Stabilization System	Dynamic Stabilization System (DSS)	Dynamic Stabilization System (DSS) System

Primary Outcome Measures

Name	Time	Method
Number of Participants Who Have an Incidence of Serious or Device Related Adverse Events Due to Device or Procedure.	6 months	The safety endpoint is defined as the incidence of serious or device related adverse events attributable to the device or procedure. Reoperations, revisions or removals of the Dynamic Stabilization System (DSS) System implant will be evaluated.

Secondary Outcome Measures

Name	Time	Method
Measurement of Left Leg Pain as Assessed by Visual Analog Scale	6 months	Left leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)
Assessment of Back Pain Using the Oswestry Low Back Pain Disability Index (ODI).	6 months	ODI is a questionnaire that provides information on back and the affects on managing every day life by diving questions into 10 sections. The total possible score for each section is 0-5. The scores are then converted into percentages ranging from 0% (minimal disability) to 100% (maximum possible disability).
Measurement of Lower Back Pain as Assessed by Visual Analog Scale	6 months	Lower back pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)
Measurement of Right Leg Pain as Assessed by Visual Analog Scale	6 months	Right leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)
Number of Participants With Improved Health as Measured by the EuroQOL Health Related Qualify of Life- 5 Dimensions-3 Level (EQ-5D-3L) Health Questionnaire Compared to Baseline.	Pre-Op, 6 weeks, 6 months, 12 months, and 24 months	The EQ-5D-3L is a standardized instrument used as a measure of health outcomes. It contains questions in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and provides a simple descriptive profile and single index for health status preference. In addition, there is a Visual Analog Scale (VAS). The VAS is the participant's rating of their health on a scale of 0 "worst imaginable health state" to 100 "best imaginable health state".